Elena V. Koroleva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elena V. Koroleva has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Zh. V. Ignatovich
Institute of Chemistry of New Materials, National Academy of Sciences of Belarus, Minsk, Belarus
19 shared publicationsA. L. Ermolinskaya
Institute of Chemistry of New Materials, National Academy of Sciences of Belarus, Minsk, Belarus
12 shared publicationsK. N. Gusak
National Academy of Sciences of Belarus
10 shared publications- Anastasia L. Ermolinskaya
Institute of Chemistry of New Materials, National Academy of Sciences of Belarus, Minsk, Belarus
4 shared publications - J. V. Siniutsich
Institute of Chemistry of New Materials, NAS of Belarus, Minsk, Belarus
4 shared publications Ya. M. Katok
Belarusian State Technological University, Minsk, Belarus
4 shared publications
Latest Publications
- 28 July 2025
- Published by Pleiades Publishing Ltd in Russian Journal of Bioorganic Chemistry
- Vol. 51 (4) , 1734-1751
Chimeric Amides of Substituted Allyl- and Phenylcarboxylic Acids with Pharmacophoric Moieties of Aromatic and Heteroaromatic Rings as Potential Multitarget Protein Kinase Inhibitors: Design, Synthesis, Evaluation of Antitumor Activity, and In Silico Analysis
Objective: This study aims to synthesize and evaluate the antitumor efficacy of a series of designed chimeric amides (10–14, 16, 19, 21, 25–27, 28, 30) containing various combinations of nitrogen-based heterocycles, which are the key pharmacophores of many antitumor drugs with different mechanisms of action. Methods: The designed amides were synthesized and characterized using spectroscopic techniques. The antitumor activity of all these compounds against tumor cell lines K562 (chronic myeloid leukemia), HL-60 (acute promyelocytic leukemia), and HeLa (cervical carcinoma) was evaluated in vitro in terms of the half-maximal inhibitory concentration (IC50). Results and Discussion: As a result, five lead compounds, amides (10, 11, 21, 27, 30), active against the above cell lines, were identified, followed by in silico analysis of their pharmacological properties and prediction of the most probable mechanism of their action against myeloid blood cells K562. Conclusions: In light of the data obtained, the identified compounds provide promising basic structures for the design of novel orally active antitumor agents, multitarget protein kinase inhibitors.
- 28 July 2025
- Published by Pleiades Publishing Ltd in Russian Journal of Bioorganic Chemistry
- Vol. 51 (4) , 1734-1751
Chimeric Amides of Substituted Allyl- and Phenylcarboxylic Acids with Pharmacophoric Moieties of Aromatic and Heteroaromatic Rings as Potential Multitarget Protein Kinase Inhibitors: Design, Synthesis, Evaluation of Antitumor Activity, and In Silico Analysis
Objective: This study aims to synthesize and evaluate the antitumor efficacy of a series of designed chimeric amides (10–14, 16, 19, 21, 25–27, 28, 30) containing various combinations of nitrogen-based heterocycles, which are the key pharmacophores of many antitumor drugs with different mechanisms of action. Methods: The designed amides were synthesized and characterized using spectroscopic techniques. The antitumor activity of all these compounds against tumor cell lines K562 (chronic myeloid leukemia), HL-60 (acute promyelocytic leukemia), and HeLa (cervical carcinoma) was evaluated in vitro in terms of the half-maximal inhibitory concentration (IC50). Results and Discussion: As a result, five lead compounds, amides (10, 11, 21, 27, 30), active against the above cell lines, were identified, followed by in silico analysis of their pharmacological properties and prediction of the most probable mechanism of their action against myeloid blood cells K562. Conclusions: In light of the data obtained, the identified compounds provide promising basic structures for the design of novel orally active antitumor agents, multitarget protein kinase inhibitors.
- 1 March 2025
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 61 (3) , 378-384
Synthesis and Antiproliferative Activity of 4-(1H-Benzimidazol-2-yl)-N-{3-[(pyrimidin-2-yl)amino]phenyl}benzamides as Potential Protein Kinase Inhibitors
The results of studying the synthesis and antiproliferative activity of new 4-(1H-benzimidazol-2-yl)benzamides containing pharmacophoric 2aminopyrimidine and pyridine moieties are reported. The target compounds were obtained by the acylation of N-(pyrimidin-2-yl)-m-phenylenediamines with 4-(1H-benzimidazol-2-yl)benzoyl chloride or by the aminolysis 4-(1H-benzimidazol-2-yl)benzoic acid with the same amines. The synthesized compounds were evaluated for their in vitro antiproliferative activity against stable human tumor cell lines K562, HL-60, RPMI 1788, and HeLa.
- 1 March 2025
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 61 (3) , 378-384
Synthesis and Antiproliferative Activity of 4-(1H-Benzimidazol-2-yl)-N-{3-[(pyrimidin-2-yl)amino]phenyl}benzamides as Potential Protein Kinase Inhibitors
The results of studying the synthesis and antiproliferative activity of new 4-(1H-benzimidazol-2-yl)benzamides containing pharmacophoric 2aminopyrimidine and pyridine moieties are reported. The target compounds were obtained by the acylation of N-(pyrimidin-2-yl)-m-phenylenediamines with 4-(1H-benzimidazol-2-yl)benzoyl chloride or by the aminolysis 4-(1H-benzimidazol-2-yl)benzoic acid with the same amines. The synthesized compounds were evaluated for their in vitro antiproliferative activity against stable human tumor cell lines K562, HL-60, RPMI 1788, and HeLa.
- 1 January 2025
- Published by Akademizdatcenter Nauka in Журнал органической химии / Russian Journal of Organic Chemistry
- Vol. 61 (2) , 159-166
Synthesis and Antiproliferative Activity of 2-Aryl-aminopyrimidine Amides of Benzimidazole-Substituted Phenylcarboxylic Acid - New Potential Protein Kinase Inhibitors
The results of a study on the synthesis and antiproliferative activity of new phenylcarboxylic acid amides, the structure of which contains pharmacophoric fragments of nitrogen-containing heterocycles - 2-aminopyrimidine, benzimidazole, pyridine, are presented. The synthesis was carried out by acylation of substituted 2-arylaminopyrimidine phenylenediamines with p-benzimidazole-phenylcarboxylic acid chloride or by aminolysis of p-benzimidazolephenylcarboxylic acid with 2-arylaminopyrimidinephenylenediamines. The potential inhibitory activity of the synthesized amides was assessed by in vitro screening of the compounds for antiproliferative activity in models of stable human tumor cell lines K562, HL-60, RPMI 1788, HeLa.
- 1 January 2025
- Published by Akademizdatcenter Nauka in Журнал органической химии / Russian Journal of Organic Chemistry
- Vol. 61 (2) , 159-166
Synthesis and Antiproliferative Activity of 2-Aryl-aminopyrimidine Amides of Benzimidazole-Substituted Phenylcarboxylic Acid - New Potential Protein Kinase Inhibitors
The results of a study on the synthesis and antiproliferative activity of new phenylcarboxylic acid amides, the structure of which contains pharmacophoric fragments of nitrogen-containing heterocycles - 2-aminopyrimidine, benzimidazole, pyridine, are presented. The synthesis was carried out by acylation of substituted 2-arylaminopyrimidine phenylenediamines with p-benzimidazole-phenylcarboxylic acid chloride or by aminolysis of p-benzimidazolephenylcarboxylic acid with 2-arylaminopyrimidinephenylenediamines. The potential inhibitory activity of the synthesized amides was assessed by in vitro screening of the compounds for antiproliferative activity in models of stable human tumor cell lines K562, HL-60, RPMI 1788, HeLa.
- 1 December 2023
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 59 (12) , 2167-2175
Synthesis of Unsymmetrically Substituted Succinic Acid Diamides Containing a Pharmacophoric 2-Aminopyrimidine Fragment as Potential Protein Kinase Inhibitors
Succinic acid diamides containing two pharmacophoric fragments, one of which is 2aminopyrimidine, and the other, N-methylpiperazine, 2-aminopyrimidine, or substituted aniline moiety, were synthesized in two steps. The synthetic scheme included acylation of substituted (pyrimidin-2-ylamino)aniline or pyrimidin-2-amine with succinic anhydride and the subsequent acylation of another heterocyclic or aromatic amine with the resulting pyrimidine-substituted succinic acid monoamide. The key intermediate products in the synthesis are succinic acid anilides. The acylation heterocyclic or aromatic amines with substituted succinic acid monochloride or amidation of succinic acid benzotriazolyl ester gave the corresponding succinic acid diamides as potential inhibitors of enzymes mediating tumorigenic processes.
- 1 December 2023
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 59 (12) , 2167-2175
Synthesis of Unsymmetrically Substituted Succinic Acid Diamides Containing a Pharmacophoric 2-Aminopyrimidine Fragment as Potential Protein Kinase Inhibitors
Succinic acid diamides containing two pharmacophoric fragments, one of which is 2aminopyrimidine, and the other, N-methylpiperazine, 2-aminopyrimidine, or substituted aniline moiety, were synthesized in two steps. The synthetic scheme included acylation of substituted (pyrimidin-2-ylamino)aniline or pyrimidin-2-amine with succinic anhydride and the subsequent acylation of another heterocyclic or aromatic amine with the resulting pyrimidine-substituted succinic acid monoamide. The key intermediate products in the synthesis are succinic acid anilides. The acylation heterocyclic or aromatic amines with substituted succinic acid monochloride or amidation of succinic acid benzotriazolyl ester gave the corresponding succinic acid diamides as potential inhibitors of enzymes mediating tumorigenic processes.
- 1 November 2023
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 93 (S1) , S56-S60
Preparative Method for Obtaining Benzylated Heterocyclic and Aromatic Amines in the Presence of Cerium-Containing Nanocatalysts
The results of application of new catalytic reagents based on cerium dioxide nanoparticles and its composites with gold, hydroxyapatite, and polyvinylpyrrolidone to the reductive alkylation of heteroaromatic and heterocyclic amines with methyl 4formylbenzoate are presented. A highly efficient method for preparation of benzylated heterocyclic and aromatic amines is proposed.
- 1 November 2023
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 93 (S1) , S56-S60
Preparative Method for Obtaining Benzylated Heterocyclic and Aromatic Amines in the Presence of Cerium-Containing Nanocatalysts
The results of application of new catalytic reagents based on cerium dioxide nanoparticles and its composites with gold, hydroxyapatite, and polyvinylpyrrolidone to the reductive alkylation of heteroaromatic and heterocyclic amines with methyl 4formylbenzoate are presented. A highly efficient method for preparation of benzylated heterocyclic and aromatic amines is proposed.
- 26 April 2022
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 41 (9) , 4065-4080
In silico design and computational evaluation of novel 2-arylaminopyrimidine-based compounds as potential multi-targeted protein kinase inhibitors: application for the native and mutant (T315I) Bcr-Abl tyrosine kinase
An integrated computational approach to drug discovery was used to identify novel potential inhibitors of the native and mutant (T315I) Bcr-Abl tyrosine kinase, the enzyme playing a key role in the pathogenesis of chronic myeloid leukemia (CML). This approach included i) design of chimeric molecules based on the 2-arylaminopyrimidine fragment, the main pharmacophore of the Abl kinase inhibitors imatinib and nilotinib used in the clinic for the CML treatment, ii) molecular docking of these compounds with the ATP-binding site of the native and mutant Abl kinase, iii) refinement of the ligand-binding poses by the quantum chemical method PM7, iv) molecular dynamics simulations of the ligand/Abl complexes, and v) prediction of the ligand/Abl binding affinity in terms of scoring functions of molecular docking, machine learning, quantum chemistry, and molecular dynamics. As a result, five top-ranking compounds able to effectively block the enzyme catalytic site were identified. According to the data obtained, these compounds exhibit close modes of binding to the Abl kinase active site that are mainly provided by hydrogen bonds and multiple van der Waals contacts. The identified compounds show high binding affinity to the native and mutant Abl kinase comparable with the one calculated for the FDA-approved kinase-targeted inhibitors imatinib, nilotinib, and ponatinib used in the calculations as a positive control. The results obtained testify to the predicted drug candidates against CML may serve as good scaffolds for the design of novel anticancer agents able to target the ATP-binding pocket of the native and mutant Abl kinase. Communicated by Ramaswamy H. Sarma
- 26 April 2022
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 41 (9) , 4065-4080
In silico design and computational evaluation of novel 2-arylaminopyrimidine-based compounds as potential multi-targeted protein kinase inhibitors: application for the native and mutant (T315I) Bcr-Abl tyrosine kinase
An integrated computational approach to drug discovery was used to identify novel potential inhibitors of the native and mutant (T315I) Bcr-Abl tyrosine kinase, the enzyme playing a key role in the pathogenesis of chronic myeloid leukemia (CML). This approach included i) design of chimeric molecules based on the 2-arylaminopyrimidine fragment, the main pharmacophore of the Abl kinase inhibitors imatinib and nilotinib used in the clinic for the CML treatment, ii) molecular docking of these compounds with the ATP-binding site of the native and mutant Abl kinase, iii) refinement of the ligand-binding poses by the quantum chemical method PM7, iv) molecular dynamics simulations of the ligand/Abl complexes, and v) prediction of the ligand/Abl binding affinity in terms of scoring functions of molecular docking, machine learning, quantum chemistry, and molecular dynamics. As a result, five top-ranking compounds able to effectively block the enzyme catalytic site were identified. According to the data obtained, these compounds exhibit close modes of binding to the Abl kinase active site that are mainly provided by hydrogen bonds and multiple van der Waals contacts. The identified compounds show high binding affinity to the native and mutant Abl kinase comparable with the one calculated for the FDA-approved kinase-targeted inhibitors imatinib, nilotinib, and ponatinib used in the calculations as a positive control. The results obtained testify to the predicted drug candidates against CML may serve as good scaffolds for the design of novel anticancer agents able to target the ATP-binding pocket of the native and mutant Abl kinase. Communicated by Ramaswamy H. Sarma
- 1 November 2021
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 57 (11) , 1868-1873
Synthesis of Novel Derivatives of 1-Metoxy-3-methylcarbazole – Murrayafoline A Alkaloid
The paper presents the results of a study on the synthesis of new derivatives of the murrayafoline alkaloid, potential inhibitors of tumor processes, which combine in their structure 2 chromatophores: 2-aminopyrimidine and murrayafoline. Pyrimidine-substituted (chloromethylphenyl)carboxylic acid amides, the key intermediates of the synthesis, were prepared by the acylation of 2-[(arylamino)amino]pyrimidine with 4-(chloromethyl)benzoyl chloride. The subsequent alkylation of 1-methoxy-3-methylcarbazole with pyrimidine-substituted (chloromethyl)phenylcarboxylic acid amides in the presence of sodium methoxide gave novel murrayafoline derivatives in yields of 60–80%. As a result of a side nucleophilic reaction with sodium methoxide, the key intermediates partially converted into methyl esters.
- 1 November 2021
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 57 (11) , 1868-1873
Synthesis of Novel Derivatives of 1-Metoxy-3-methylcarbazole – Murrayafoline A Alkaloid
The paper presents the results of a study on the synthesis of new derivatives of the murrayafoline alkaloid, potential inhibitors of tumor processes, which combine in their structure 2 chromatophores: 2-aminopyrimidine and murrayafoline. Pyrimidine-substituted (chloromethylphenyl)carboxylic acid amides, the key intermediates of the synthesis, were prepared by the acylation of 2-[(arylamino)amino]pyrimidine with 4-(chloromethyl)benzoyl chloride. The subsequent alkylation of 1-methoxy-3-methylcarbazole with pyrimidine-substituted (chloromethyl)phenylcarboxylic acid amides in the presence of sodium methoxide gave novel murrayafoline derivatives in yields of 60–80%. As a result of a side nucleophilic reaction with sodium methoxide, the key intermediates partially converted into methyl esters.
- Open Access
One-Step Synthesis of Magnetic Nanocomposite with Embedded Biologically Active Substance
Magnetic nanocomposites based on hydroxyapatite were prepared by a one-step process using the hydrothermal coprecipitation method to sinter iron oxides (Fe3O4 and γ-Fe2O3). The possibility of expanding the proposed technique for the synthesis of magnetic composite with embedded biologically active substance (BAS) of the 2-arylaminopyrimidine group was shown. The composition, morphology, structural features, and magnetic characteristics of the nanocomposites synthesized with and without BAS were studied. The introduction of BAS into the composite synthesis resulted in minor changes in the structural and physical properties. The specificity of the chemical bonds between BAS and the hydroxyapatite-magnetite core was revealed. The kinetics of the BAS release in a solution simulating the stomach environment was studied. The cytotoxicity of (HAP)FexOy and (HAP)FexOy + BAS composites was studied in vitro using the primary culture of human liver carcinoma cells HepG2. The synthesized magnetic composites with BAS have a high potential for use in the biomedical field, for example, as carriers for magnetically controlled drug delivery and materials for bone tissue engineering.
Open AccessOne-Step Synthesis of Magnetic Nanocomposite with Embedded Biologically Active Substance
Magnetic nanocomposites based on hydroxyapatite were prepared by a one-step process using the hydrothermal coprecipitation method to sinter iron oxides (Fe3O4 and γ-Fe2O3). The possibility of expanding the proposed technique for the synthesis of magnetic composite with embedded biologically active substance (BAS) of the 2-arylaminopyrimidine group was shown. The composition, morphology, structural features, and magnetic characteristics of the nanocomposites synthesized with and without BAS were studied. The introduction of BAS into the composite synthesis resulted in minor changes in the structural and physical properties. The specificity of the chemical bonds between BAS and the hydroxyapatite-magnetite core was revealed. The kinetics of the BAS release in a solution simulating the stomach environment was studied. The cytotoxicity of (HAP)FexOy and (HAP)FexOy + BAS composites was studied in vitro using the primary culture of human liver carcinoma cells HepG2. The synthesized magnetic composites with BAS have a high potential for use in the biomedical field, for example, as carriers for magnetically controlled drug delivery and materials for bone tissue engineering.
- 1 December 2020
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 56 (12) , 2092-2097
Synthesis of 4,4′-Oxydibenzoic Acid Amides and Sulfonamides Containing 2-Arylaminopyrimidine Moieties
New 4,4′-oxydibenzamides and sulfamoyl derivatives of 4,4′-oxydibenzoic acid containing pharmacophoric 2-arylaminopyrimidine fragments in the amide moiety have been synthesized. Acylation of amines of the pyrimidine series with 2-chlorosulfonyl-substituted 4,4′-oxydibenzoic acid gave the corresponding sulfonamides. Arylaminopyrimidine derivatives of 4,4′-oxydibenzamide were obtained in 75–87% yield by acylation of 3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}anilines with 4,4′-oxydibenzoyl chloride. The reactivity of 4,4′-oxydibenzoyl chloride toward amines is discussed.
- 1 December 2020
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 56 (12) , 2092-2097
Synthesis of 4,4′-Oxydibenzoic Acid Amides and Sulfonamides Containing 2-Arylaminopyrimidine Moieties
New 4,4′-oxydibenzamides and sulfamoyl derivatives of 4,4′-oxydibenzoic acid containing pharmacophoric 2-arylaminopyrimidine fragments in the amide moiety have been synthesized. Acylation of amines of the pyrimidine series with 2-chlorosulfonyl-substituted 4,4′-oxydibenzoic acid gave the corresponding sulfonamides. Arylaminopyrimidine derivatives of 4,4′-oxydibenzamide were obtained in 75–87% yield by acylation of 3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}anilines with 4,4′-oxydibenzoyl chloride. The reactivity of 4,4′-oxydibenzoyl chloride toward amines is discussed.